Home/Venturis Therapeutics/Robert Schleizer

RS

Robert Schleizer

Chief Financial Officer (CFO)

Venturis Therapeutics

Therapeutic Areas

Cardiovascular Metabolic Disorders Neurology Urology Musculoskeletal

Venturis Therapeutics Pipeline

Drug	Indication	Phase
FGF-based Therapeutic	Diabetic Wounds / Severe Ischemic Heart Disease / Peripheral Artery Disease	Phase 2

Leadership Team at Venturis Therapeutics

Calvin A. Wallen III

President, Chairman of the Board

David G. Armstrong, DPM, MD, PhD

Affiliated Clinical Advisor (Diabetic Foot)

View full Venturis Therapeutics profile